Another small company's arbitration against CRO that screwed them --

https://endpts.com/arbitration-panel-sides-wi...nrollment/

Quote:

---

The contract research organization Syneos Health didn’t hold up its end of the deal and use “commercially reasonable efforts” when setting up a trial for a biotech client, an arbitration panel found. It also determined that the client owes the CRO about $1.7 million in damages — less than half of what Syneos was asking for in payment.

FSD Pharma, which contracted Syneos to set up a Phase II trial in 2021 for one of its drug candidates dubbed FSD 210, claimed in a statement Monday that Syneos failed to enroll the expected number of patients and hit enrollment deadlines.

---

The small company had to pay 1.7 million to the rotten CRO because they didn't dispute the bills "properly," whatever that means.